Canakinumab

Strategies to optimize Phase III combination immunotherapy trials 1:44
Strategies to optimize Phase III combination immunotherapy trials
Thomas Urban Marron • 16 Apr 2023
Biological mechanisms of lung cancer initiation and progression 2:02
Biological mechanisms of lung cancer initiation and progression
Charles Swanton • 12 Sep 2022
Highlights in lung cancer at ESMO 2022 1:54
Highlights in lung cancer at ESMO 2022
Melissa Johnson • 15 Sep 2022
CANOPY-A: canakinumab for resected NSCLC 1:30
CANOPY-A: canakinumab for resected NSCLC
Alexander Spira • 7 Apr 2021
Treating cancer during the COVID-19 pandemic 2:40
Treating cancer during the COVID-19 pandemic
Federico Cappuzzo • 22 Mar 2021
CANOPY-A: canakinumab for early stage NSCLC 3:37
CANOPY-A: canakinumab for early stage NSCLC
David Spigel • 28 May 2020
The content of VJOncology is intended for healthcare professionals